Non-OpeRative MANagement of Rectal Cancer Patients
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Chemoradiotherapy
- Rectal Cancer
- Watch & Wait
- Type
- Interventional
- Phase
- Early Phase 1
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Aim: 1) to analyze the treatment results after receiving capecitabine adjuvant chemotherapy for 4 months after non-surgical treatment in patients who had completed and could have clinical complete remission with capecitabine preoperative chemoradiotherapy with capecitabine for mid-to-lower rectal cancer 2) to investigate the feasibility of non-surgical treatment.Masking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 20 years and 100 years
- Gender
- Both males and females
Description
Indication: mid-to-lower rectal cancer was diagnosed histologically as adenocarcinoma in preoperative examination, the tumor was located at the lower boundary of the tumor spans the anorectal junction, and the clinical stage is stage 2 or 3, and clinical complete remission was confirmed after the tr...
Indication: mid-to-lower rectal cancer was diagnosed histologically as adenocarcinoma in preoperative examination, the tumor was located at the lower boundary of the tumor spans the anorectal junction, and the clinical stage is stage 2 or 3, and clinical complete remission was confirmed after the treatment response evaluation at 8 weeks after completion of preoperative chemoradiotherapy according to MR/SFS and biopsy. Aim: to analyze the treatment results after receiving capecitabine adjuvant chemotherapy for 4 months after non-surgical treatment in patients who had completed and could have clinical complete remission with capecitabine preoperative chemoradiotherapy with capecitabine for mid-to-lower rectal cancer to investigate the feasibility of non-surgical treatment.
Tracking Information
- NCT #
- NCT04696757
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Dong-Hoe Koo Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine
Get Well Soon